Analysts Set Stem, Inc. (NYSE:STEM) Target Price at $2.71

Stem, Inc. (NYSE:STEMGet Free Report) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are presently covering the stock, Marketbeat Ratings reports. Ten equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $2.72.

Several research firms recently commented on STEM. The Goldman Sachs Group reduced their price objective on shares of Stem from $1.40 to $0.75 and set a “neutral” rating for the company in a research note on Thursday, August 8th. UBS Group lowered their price objective on Stem from $2.50 to $1.00 and set a “buy” rating for the company in a research report on Thursday, August 8th. Evercore ISI decreased their price target on Stem from $9.00 to $5.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. TD Cowen downgraded shares of Stem from a “buy” rating to a “hold” rating and cut their price objective for the company from $4.00 to $1.00 in a report on Wednesday, August 7th. Finally, Susquehanna lifted their target price on shares of Stem from $0.50 to $0.60 and gave the stock a “neutral” rating in a research note on Wednesday.

Check Out Our Latest Stock Report on Stem

Stem Price Performance

Shares of STEM stock opened at $0.58 on Friday. Stem has a twelve month low of $0.30 and a twelve month high of $4.30. The company has a current ratio of 1.66, a quick ratio of 1.51 and a debt-to-equity ratio of 1.41. The stock has a fifty day simple moving average of $0.49 and a two-hundred day simple moving average of $1.06. The stock has a market capitalization of $93.53 million, a price-to-earnings ratio of -0.12 and a beta of 1.68.

Stem (NYSE:STEMGet Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.01. The firm had revenue of $34.00 million for the quarter, compared to the consensus estimate of $64.06 million. Stem had a negative net margin of 213.33% and a negative return on equity of 63.98%. The company’s quarterly revenue was down 63.4% on a year-over-year basis. During the same period last year, the firm earned ($0.56) earnings per share. On average, analysts predict that Stem will post -0.66 EPS for the current fiscal year.

Institutional Trading of Stem

Large investors have recently made changes to their positions in the business. Wellington Wealth Strategies LLC. purchased a new position in shares of Stem during the fourth quarter worth $66,000. Clarity Capital Partners LLC purchased a new position in shares of Stem during the 4th quarter valued at about $392,000. Virtu Financial LLC acquired a new position in shares of Stem in the 4th quarter valued at about $228,000. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Stem by 90.3% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 222,575 shares of the company’s stock worth $487,000 after buying an additional 105,643 shares during the last quarter. Finally, GSA Capital Partners LLP acquired a new stake in Stem during the first quarter worth about $513,000. 61.63% of the stock is owned by hedge funds and other institutional investors.

Stem Company Profile

(Get Free Report

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.

Featured Stories

Analyst Recommendations for Stem (NYSE:STEM)

Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.